Patents for C07G 3 - Glycosides (647)
05/2011
05/05/2011WO2011050442A1 Gallotannic compounds for lithographic printing plate coating compositions
05/05/2011CA2763435A1 Gallotannic compounds for lithographic printing plate coating compositions
04/2011
04/26/2011US7932379 Methods of producing C-aryl glucoside SGLT2 inhibitors
03/2011
03/01/2011US7897736 Fluorescent quenching detecting reagents and methods
02/2011
02/22/2011US7893224 Oligonucleotides comprising a ligand tethered to a modified or non-natural nucleobase
02/15/2011US7888487 Pyrazole derivative, medicinal composition containing the same, medicinal use thereof and intermediate in producing the same
02/08/2011US7883869 for sequencing single-stranded DNA by employing a nanopore and modified nucleotides
01/2011
01/25/2011US7875707 combinatorial libraries; lipid solubility; solid phase synthesis
12/2010
12/29/2010EP2265625A1 Method of continuous acid hydrolysis of cellulose containing substances
12/14/2010US7851157 Oligonucleotide derivative, probe for detection of gene, and DNA chip
11/2010
11/18/2010US20100292448 Sleeve Valve
10/2010
10/19/2010US7816330 Substituted benzimidazole-, benztriazole-, and benzimidazolone-O-glucosides
10/07/2010US20100256077 Core 2GlcNAc-T inhibitors
09/2010
09/23/2010US20100240879 Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivates and intermediates therein
09/07/2010US7790699 Self-gelling alginate systems and uses thereof
08/2010
08/24/2010US7781572 Nanosized carotenoid cyclodextrin complexes
08/10/2010US7772381 Efficient method to synthesize benzyl group-protected alpha-pentagalloylglucose (α-PGG) and its analogues
08/05/2010US20100197615 Synthesis of compounds useful as modulators of amyloid-beta production
07/2010
07/20/2010US7759470 Labeling reagent
07/20/2010US7759469 substituted indole nucleosides as both terminal as well as internal building blocks of labeled oligonucleotide probes for the detection, analysis and quantitation of nucleic acids; nucleoside with a 3-substituted methanesulfonylamino indole as nucleobase
07/13/2010US7754864 Tyrosinase activity controlling agent, process for producing the same and external preparation containing the same
06/2010
06/10/2010US20100144045 Chiral selectors for separating enantiomers of a compound
06/10/2010US20100143975 Monoterpenoid modifying enzymes
06/08/2010US7732583 efficient synthetic methods for economically mass producing glycolipids having an immunosuppressive action useful for the treatment of autoimmune diseases; 1,3-O-benzylidene-D-arabino-1,2,3,4-octanetetraol
05/2010
05/19/2010EP1490359B1 Detection of glucose in solutions also containing an alpha-hydroxy acid or a beta-diketone
05/11/2010US7713698 Determining sequence of preferential DNA sequences
05/06/2010WO2010051227A1 Galactose alpha (1-3) galactose compositions
04/2010
04/22/2010US20100099857 Method of producing purified rebaudioside a compositions using solvent/antisolvent crystallization
04/15/2010US20100092585 Plant extraction method and compositions
04/01/2010WO2009037592A3 Triazole-based aminoglycoside-peptide conjugates and methods of use
03/2010
03/31/2010EP2167522A2 Triazole-based aminoglycoside-peptide conjugates and methods of use
03/16/2010US7678892 Dye-labeled ribonucleotide triphosphates
02/2010
02/23/2010US7666847 Medicament comprising a reducing alkyl-sugar monomer for the treatment of inflammatory disorders
02/17/2010CN101652377A Benzylic glycoside derivatives and methods of use
02/16/2010US7662938 2′-fluoronucleosides
02/16/2010CA2533548C Method of purifying macrolides
02/11/2010US20100035831 Anti-wrinkle agent and adam inhibitor
02/02/2010US7655768 Galactose derivative, drug carrier and medicinal composition
01/2010
01/26/2010US7652130 enhances feel of oil in water emulsions containing polymers as as thickeners, emulsifiers or stabilizers; reacting a branched alkyl Guerbet alcohol having 16 to 28 carbon atoms with xylose; etherification and condensation
01/07/2010US20100004188 Substituted benzimidazole-, benztriazole-, and benzimidazolone-o-glucosides
11/2009
11/24/2009US7622279 DNA or RNA comprising self-priming moiety are bound to a solid substrate via 1,3-dipolar azide-alkyne cycloaddition chemistry
10/2009
10/20/2009US7605241 Synthesis of inhibitors of p90Rsk
10/14/2009CN100549009C Composition for detection of glucose in solutions also containing an alpha-hydroxy acid or a beta-diketone and method thereof
09/2009
09/24/2009WO2009116885A1 Method of continuous acid hydrolysis of cellulose containing substances
09/03/2009US20090221806 Method for Producing a Beta-1,3-Glucan With Improved Characteristics
08/2009
08/20/2009US20090209746 Method of Preparing a Glycoside of a Mono or Diacylglycerol Product From a Plant Material
08/18/2009US7576071 Antithrombotic compound
08/05/2009CN100522982C Production process for extracting tea saponin from tea-oil tree cake by using water as dissoluent
07/2009
07/23/2009US20090187013 Synthetic heparin pentasaccharides
07/07/2009US7556967 Foldable polymers as probes
06/2009
06/23/2009US7550570 4,7-dichlororhodamine dyes labeled polynucleotides
06/02/2009US7541020 Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors
05/2009
05/28/2009US20090137499 Benzylphenyl glucopyranoside derivative
05/19/2009US7534770 extract of a plant of the family Liliaceae; Aloe vera; can be safely ingested without causing acute hypoglycemia and has a long-term blood glucose level control action to decrease the hemoglobin Alc level
05/07/2009US20090117214 Extract Of Fraxinus Excelsior Seeds And Therapeutic Applications Therefor
04/2009
04/30/2009US20090111975 Method for the synthesis of anthocyanins
04/23/2009US20090105165 Substituted benzimidazole-, benztriazole-, and benzimidazolone-o-glucosides
04/08/2009CN100475753C Use of plant extract of anoectochilus formosanus and fraction originating from the same as galenicals or dietary supplement for chemical defense or treatment of human malignant lesion
04/07/2009US7514541 crosslinking with curing agents in acidic or alkaline conditions, to form to products used in cosmetic, medical and pharmaceutical applications
04/01/2009CN101397312A Technology for extract saponin by using ethanol instead of gasoline
03/2009
03/31/2009US7511020 2-[3-(4-Ethyl-benzyl)-3H-benzoimidazol-4-yloxy]- .squ. -D-glucoglucopyranoside; sodium glucose transporter inhibitor; antidiabetic agent; Syndrome X, obesity, nephropathy, neuropathy, retinopathy, atherosclerosis, hypertension, ischemia, stroke, heart disease, irritable bowel disorder, and cataracts
03/26/2009WO2009037592A2 Triazole-based aminoglycoside-peptide conjugates and methods of use
03/26/2009CA2687689A1 Triazole-based aminoglycoside-peptide conjugates and methods of use
03/17/2009US7504496 Water-soluble rhodamine dye conjugates
03/17/2009US7504489 enzyme inhibitors such as beta-1'-nicotinamide-2'-deoxyribose, used for treating diseases and conditions associated with CD38, related enzymes and cyclic-adenosine-diphosphate-ribose (cADPR)
03/17/2009US7504208 Deblocking, deprotecting 18F-labeled tracer; ion exchange chromatography; cartrigdes, radiopharmaceutical kits; diagnostic positron emission tomography; pharmacokinetics
03/12/2009US20090069551 Flavorant Compounds
02/2009
02/26/2009US20090054355 Proliferation Inhibitor Of Helicobacter Pylori Including Alpha-N-Acetyl-Glucosaminyl Bond-Containing Monosaccharide Derivatives
02/19/2009US20090048184 Method for Producing a Drug Extract That Contains Hydroxystilbene
01/2009
01/13/2009US7476727 Conjugates of mycophenolic acid
12/2008
12/25/2008US20080318874 Novel Cyclohexane Derivative, Prodrug Thereof and Salt Thereof, and Therapeutic Agent Containing the Same for Diabetes
12/24/2008CN101328194A Persimmon powder and production process thereof
12/17/2008CN100443497C Method for extraction of ginseng fruit glucoside
12/10/2008CN100441592C Method for extraction of American ginseng fruit glucoside
12/04/2008US20080300392 Novel chlorination process for preparing sucralose
11/2008
11/27/2008US20080293643 Crystalline Form I of 3,4'5-Trihydroxy-Stilbene-3-B-D Glucoside
11/25/2008US7456266 Detectable labeled nucleoside analogs and methods of use thereof
11/19/2008CN101307083A Method for acid-hydrolyzing propolis flavonoid glycoside
11/04/2008US7445902 Fluorescent nucleotide analogues
10/2008
10/28/2008US7442687 2-polycyclic propynyl adenosine analogs having A2A agonist activity
10/21/2008US7439344 One step
10/21/2008US7439232 Heteroaryl 5-thio-β-D-glucopyranoside derivatives and therapeutic agents for diabetes containing the same
10/15/2008CN100425253C Process for preparing total saponin of anemone rhizome
10/09/2008WO2008122014A1 Benzylic glycoside derivatives and methods of use
09/2008
09/10/2008CN101260130A Methods of producing C-aryl glucoside SGLT2 inhibitors
09/09/2008US7423133 Fluorescent glycosides and methods for their use
08/2008
08/26/2008US7417031 Induction apoptosis; oxidation resistance; preservatives
08/26/2008US7416719 Sunscreen compositions
08/21/2008US20080200401 Mixing powdered oleander leaf with supercritical carbon dioxide above critical pressure and critical temperature; depressurization and cooling to give a separated extract mixture; recovering cardiac glycoside-containing extract which acts as an antiproliferative agent; solvent extraction
08/06/2008EP1951740A2 High affinity siglec ligands
08/06/2008CN101237771A Multidrug resistant anticancer anthracyclines
08/06/2008CN101235056A Method for preparing plants total glycosides
07/2008
07/30/2008CN101229204A Process for preparing bupleurum total saponin
07/29/2008US7405281 Fluorescent nucleotide analogs and uses therefor
06/2008
06/24/2008US7390782 Methods and products related to metabolic interactions in disease
06/11/2008CN100393737C Method for picking up saponin of tea
06/05/2008US20080132455 Process For Producing Enriched Fractions Containing Up To 100% Of Bacopasaponins From The Plant Materials Of Bacopa Species
06/04/2008CN100391963C Methods of producing C-aryl glucoside SGLT2 inhibitors
05/2008
05/20/2008US7375213 inhibitors of sodium dependent glucose transporters found in the intestine and kidney (SGLT2), and more particularly to a process of producing such compounds, for example dapagliflozin
05/20/2008US7375090 inhibitory effect on sodium-dependent glucose cotransporter; for the treatment of diseases, particularly metabolic disorders such as diabetes; e.g. 1-(2-propyn-1-yl)-3-( beta -D-glucopyranosyloxy)-4-(4-ethylbenzyl)-5-methyl-1H-pyrazole
1 2 3 4 5 6 7